Results 141 to 150 of about 6,340 (200)

Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat. [PDF]

Exp Ther Med, 2021
Zhang H, Dong M, Liu X.
europepmc   +1 more source

Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world. [PDF]

JHEP Rep
Terracciani F, De Vincentis A, D'Amato D, Cristoferi L, Gerussi A, Invernizzi P, Scaravaglio M, Vanni E, Campion D, Morgando A, Valiani V, Boccaccio V, Morisco F, Surace L, Cavalli I, Delle Monache G, Salomone F, Ieluzzi D, Angrisani D, Tortora R, Cuffari B, Moretti A, Nardone G, Fagiuoli S, Viganò M, Vettori G, Cerini F, Gimignani G, Mattalia A, Pizzolante F, De Matthaeis N, Rigamonti C, Manfredi GF, Boano V, Begini P, Lleo A, Colapietro F, Plebani R, Alvaro D, Venere R, Degasperi E, Borghi M, Lampertico P, Giannini EG, Labanca S, Viganò R, D'Amico F, Castellaneta A, Squeo F, Cadamuro L, Capodicasa L, Marzioni M, Buzzanca V, Poggi G, Mussetto A, Cozzolongo R, Losito F, Bertino G, Russello M, Cannavò M, Scivetti P, Pompili M, Tortora A, Niro AG, Cotugno R, Pozzoni P, Riva A, Chessa L, Miglianti M, Cuccorese G, Pace Palitti V, Abenavoli L, Terreni N, Zolfino T, Morelli O, Saitta C, Casella S, Pellicelli A, Brunetto M, Coco B, Galli A, Marra F, Curto A, Floreani A, Cazzagon N, Rollo P, Bonaiuto E, Simone L, Muratori L, Rosina F, Distefano M, Capello E, Bellia V, Sacco R, Alagna G, Baiocchi L, Crocé LS, Ricci C, Poisa P, Izzi A, Boninsegna S, Calvaruso V, Carbone M, Vespasiani-Gentilucci U, “Italian PBC registry” and the “Club Epatologi Ospedalieri” PBC working group.   +104 more
europepmc   +1 more source

Comparing the Efficacy and Safety of Obeticholic Acid and Semaglutide in Patients With Non-Alcoholic Fatty Liver Disease: A Systematic Review. [PDF]

Cureus, 2022
Ahmed NR, Kulkarni VV, Pokhrel S, Akram H, Abdelgadir A, Chatterjee A, Khan S.   +6 more
europepmc   +1 more source

How to Face Chronic Liver Disease: The Sinusoidal Perspective [PDF]

, 2017
Anabel Fernández-Iglesias, Jordi Gracia-Sancho   +1 more
core   +1 more source

Efficacy and Safety of Obeticholic Acid for Treating Hepatic Steatosis in Patients With Familial Partial Lipodystrophy.

J Clin Endocrinol Metab
Garg A, Vasandani C, Li X, Quittner C, Yokoo T.   +4 more
europepmc   +1 more source

Tailoring obeticholic acid activity by iridium(III) complex conjugation to develop a farnesoid X receptor probe. [PDF]

J Adv Res
Niu D, Wu X, Zhang Y, Wang X, Shiu-Hin Chan D, Jing S, Wong CY, Wang W, Leung CH.   +8 more
europepmc   +1 more source

Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study design. [PDF]

Hepatology
Brookhart MA, Mayne TJ, Coombs C, Breskin A, Ness E, Bessonova L, Chu YJ, Li J, Fried MW, Hansen BE, Kowdley KV, Jones D, Mells G, Trivedi PJ, Hiu S, Kareithi DN, Wason J, Smith R, Seeger JD, Hirschfield GM.   +19 more
europepmc   +1 more source

Non-alcoholic fatty liver disease [PDF]

, 2017
Brent A. Neuschwander-Tetri
core   +1 more source

Obeticholic Acid Improves Cholestasis, Liver Fibrosis, and Liver Function in Patients with Primary Biliary Cholangitis with Inadequate Response to Ursodeoxycholic Acid. [PDF]

J Pers Med
Buechter M, Manka P, Bulut K, Gerken G, Kahraman A.   +4 more
europepmc   +1 more source

COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls. [PDF]

Am J Gastroenterol
Kowdley KV, Hirschfield GM, Coombs C, Malecha ES, Bessonova L, Li J, Rathnayaka N, Mells G, Jones DE, Trivedi PJ, Hansen BE, Smith R, Wason J, Wason J, Hiu S, Kareithi DN, Mason AL, Bowlus CL, Muller K, Carbone M, Berenguer M, Milkiewicz P, Adekunle F, Villamil A.   +23 more
europepmc   +1 more source